Brief: Firebrick Pharma Announces Share Purchase Plan
12/09/2024 02:28
Sept 12 (Reuters) - Firebrick Pharma Ltd FRE.AX :
* SHARE PURCHASE PLAN AT AN ISSUE PRICE OF A$0.055 PER SHARE
* INTENDS TO RAISE UP TO A$2 MILLION PURSUANT TO SPP
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement